“To build a global biotechnology-pharmaceutical business around two first-in-class drug technology platforms.
To bring both drug technology platforms onto the market as standard first-line therapies for most forms of cancer.”
Dr Graham Kelly, Executive Chairman
CAPITAL RAISING INFORMATION
More information about ASX BookBuild
Information on the ASX BookBuild Facility can be found on the ASX website on the links below.